Free tool
Oncology stocks
We cover 8 companies grouped under the Oncology theme. The median market value in the group is $188.36M. Across the group, the median move over the past trading day is +2.77%. Price change over the past year runs from −80.7% to +221.5% across the middle 80 percent of the group, with a median of −12.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% | Oct 19, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% | Oct 8, 2026 |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% | Sep 29, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +1.34% | Sep 17, 2026 |
| ANIX | Anixa Biosciences, Inc. | $123.16M | Small cap | +22.00% | Sep 9, 2026 |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% | Sep 2, 2026 |
| BLRX | BioLineRx Ltd. | $12.45M | Micro cap | −25.97% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −87.99% | Sep 28, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.